TY - JOUR AU - Harris, Patrick N. A. AU - Yin, Mo AU - Jureen, Roland AU - Chew, Jonathan AU - Ali, Jaminah AU - Paynter, Stuart AU - Paterson, David L. AU - Tambyah, Paul A. PY - 2015 DA - 2015/04/23 TI - Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae JO - Antimicrobial Resistance and Infection Control SP - 14 VL - 4 IS - 1 AB - Extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae are often susceptible in vitro to β-lactam/β-lactamase inhibitor (BLBLI) combination antibiotics, but their use has been limited by concerns of clinical inefficacy. We aimed to compare outcomes between patients treated with BLBLIs and carbapenems for bloodstream infection (BSI) caused by cefotaxime non-susceptible (likely ESBL- or AmpC β-lactamase-producing) Escherichia coli and Klebsiella pneumoniae. SN - 2047-2994 UR - https://doi.org/10.1186/s13756-015-0055-6 DO - 10.1186/s13756-015-0055-6 ID - Harris2015 ER -